Subhasis Chattopadhyay
Overview
Explore the profile of Subhasis Chattopadhyay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
608
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chatterjee S, Kumar S, Mamidi P, Datey A, Sengupta S, Mahish C, et al.
J Virol
. 2022 Nov;
96(23):e0133422.
PMID: 36377875
Viruses utilize a plethora of strategies to manipulate the host pathways and hijack host machineries for efficient replication. Several DNA and few RNA viruses are reported to interact with proteins...
12.
Kumar P, Radhakrishnan A, Mukherjee T, Khamaru S, Chattopadhyay S, Chattopadhyay S
Virus Res
. 2022 Oct;
323:198992.
PMID: 36309316
Transient receptor potential (TRP) channels are a superfamily of cation-specific permeable channels primarily conducting Caions across various membranes of the cell. The perturbation of the Ca homeostasis is the hallmark...
13.
Kumar P, Mukherjee T, Khamaru S, Radhakrishnan A, Nanda-Kishore D, Chawla S, et al.
J Biosci
. 2022 Oct;
47.
PMID: 36222164
Correction to: J. Biosci. (2022) 47:42 https://doi.org/10.1007/s12038-022-00279-2 In the Journal of Biosciences article titled ''Elevation of TRPV1 expression on T-cells during experimental immunosuppression'' by P Sanjai Kumar et al. (https://doi.org/10.1007/s12038-022-00279-2;...
14.
De S, Ghosh S, Keshry S, Mahish C, Mohapatra C, Guru A, et al.
Antimicrob Agents Chemother
. 2022 Jun;
66(7):e0046322.
PMID: 35766508
The increase in disease incidences and persistent Chikungunya virus (CHIKV)-induced arthritis have been a huge burden on public health globally. In the absence of specific antivirals or vaccines, it is...
15.
Mamidi P, Nayak T, Kumar A, Kumar S, Chatterjee S, De S, et al.
PLoS Pathog
. 2021 Nov;
17(11):e1009667.
PMID: 34780576
Chikungunya virus (CHIKV) epidemics around the world have created public health concern with the unavailability of effective drugs and vaccines. This emphasizes the need for molecular understanding of host-virus interactions...
16.
De S, Mamidi P, Ghosh S, Keshry S, Mahish C, Pani S, et al.
Antimicrob Agents Chemother
. 2021 Nov;
66(1):e0148921.
PMID: 34748384
Chikungunya virus (CHIKV) has reemerged as a global public health threat. The inflammatory pathways of the renin-angiotensin system (RAS) and peroxisome proliferator-activated receptor-gamma (PPAR-γ) are usually involved in viral infections....
17.
Kumar P, Nayak T, Mahish C, Sahoo S, Radhakrishnan A, De S, et al.
Arch Virol
. 2020 Oct;
166(1):139-155.
PMID: 33125586
Chikungunya virus (CHIKV), a virus that induces pathogenic inflammatory host immune responses, is re-emerging worldwide, and there are currently no established antiviral control measures. Transient receptor potential vanilloid 1 (TRPV1),...
18.
Sahoo S, Majhi R, Tiwari A, Acharya T, Kumar P, Saha S, et al.
Biosci Rep
. 2019 Sep;
39(9).
PMID: 31488616
Transient receptor potential channel subfamily A member 1 (TRPA1) is a non-selective cationic channel, identified initially as a cold sensory receptor. TRPA1 responds to diverse exogenous and endogenous stimuli associated...
19.
Nayak T, Mamidi P, Sahoo S, Kumar P, Mahish C, Chatterjee S, et al.
Front Immunol
. 2019 Apr;
10:786.
PMID: 31031770
Chikungunya virus (CHIKV), a mosquito-borne Alphavirus, is endemic in different parts of the globe. The host macrophages are identified as the major cellular reservoirs of CHIKV during infection and this...
20.
Saswat T, Sahoo N, Muduli S, Debata N, Chattopadhyay S, Chattopadhyay S
J Med Virol
. 2018 Sep;
91(2):163-170.
PMID: 30192396
Chikungunya virus (CHIKV) infection is spatiotemporally related to dengue virus (DENV) infection and mostly undiagnosed due to similar primary symptoms. In 2013, a high rate (36%) of coinfection of DENV...